To evaluate the accuracy of a magnetic resonance imaging (MRI)‐based Likert scoring system in the detection of clinically significant prostate cancer (CSPC), using MRI/ultrasonography (US) image‐fusion targeted biopsy (FTB) as… Click to show full abstract
To evaluate the accuracy of a magnetic resonance imaging (MRI)‐based Likert scoring system in the detection of clinically significant prostate cancer (CSPC), using MRI/ultrasonography (US) image‐fusion targeted biopsy (FTB) as a reference standard.
               
Click one of the above tabs to view related content.